Tetiana Aleksandrova is the CEO and co-founder of Subsense, a neurotechnology company developing the world’s first non-surgical, nanoparticle-based brain-computer interface (BCI). A deep-tech entrepreneur and one of the few women leaders in neurotechnology, she has spent the past decade advancing interfaces that decode and influence neural activity. Prior to Subsense, she co-founded Neiry, leading international expansion and raising $8M for neurocognitive training devices. Across her career, she has managed over $30M in venture investment and built strong scientific teams.
Tetiana launched Subsense with a mission to unlock human potential by creating safe, scalable BCIs that transform healthcare and human-machine interaction. In under two years, she has raised $20M in seed funding, built collaborations with ETH Zurich and UC Santa Cruz, and positioned Subsense as a category-defining player in non-surgical neurotechnology. Under her leadership, Subsense won the 2025 MedTech Breakthrough Award for Best New Technology Solution – Neurology, and she was recognized at the Pinnacle Awards as the Breakthrough Medical Device Winner in Healthcare. Her work has also been honored by Top 100 Women in Tech, Top 100 Women in Venture, and Top 100 Startups.
Tetiana has shared insights on neurotechnology and the future of human potential at TEDx, GoGlobal, Women in Tech Global Conference, DeviceTalks West and VRDays. She has been published in Technology Networks, appeared on podcasts including DeviceTalks Weekly, State of Medtech, and Longevity Technology and featured in Forbes, The Wall Street Journal, Fortune, Axios, and Endpoints, among others and is a champion for responsible, inclusive neurotechnology.